Novo Nordisk A/S. Every tracked FinTwit mention of $NVO, newest first. 137 mentions since the first on Jul 29, 2025. See the price chart.
June 2026 · 1 mention
Jun 3
The Future Investors — $NVO Novo Nordisk has launched its Wegovy weight-loss pill in the UAE making it the first country outside the U.S. where the treatment is available 💊🇦🇪
More international launc…↗
May 2026 · 10 mentions
May 31
InvestmentGuru — Everyone’s asking what to buy in 2026.
The answer’s been in the executive orders the whole time.
The reshoring of America is real. And it starts with the ground-level stuff nobo…↗
May 24
InvestmentGuru — THE THEMATIC WATCHLIST — 2025 EDITION
Every mega-trend. Every sector. One list.This is how I’m thinking about capital allocation across the next cycle 👇
AI
→ $GOOGL $PLTR $NVDA $…↗
May 14
Shay Boloor — $HIMS is now accepting orders for the $NVO Ozempic Pill on its website at $149/month.
Hims is expanding its branded GLP-1 offering beyond injections giving the platform another wa…↗
The Future Investors — $NVO $LLY Novo Nordisk is extending its early lead in the oral obesity race, with Wegovy ramping much faster than Eli Lilly’s Foundayo 💊
Week 2 Prescriptions 📊
Wegovy: 18.4K
F…↗
Apr 20
Adam Feuerstein ✡️ — $AGIO -16% on $NVO study outcome in sickle cell disease.↗
Apr 17
Serenity — It’s still pretty incredible $HIMS is down 44% even after:
1. $NVO de-risking + partnership
2. Multiple global acquisitions expanding DTC distribution network
3. Peptide arc, with…↗
Apr 15
Serenity — This announcement is the most bullish catalyst for $HIMS revenue re-acceleration to date.
This is amid:
- 30%+ of the float sold short
- new $NVO partnership/lawsuit dropped
- new…
March 2026 · 10 mentions
Mar 31
The Future Investors — $NVO Novo Nordisk launched Wegovy subscription plans (3-12 months) in the US , offering lower, predictable monthly pricing with savings up to $1,200/year 💉💸 https://t.co/Mlz5pU6s…↗
Mar 19
The Future Investors — $NVO FDA approved a higher-dose version of Novo Nordisk’s Wegovy 💉
In trials, the new dose helped patients lose 20.7% of body weight over 72 weeks and is expected to launch in Ap…↗
Mar 15
mon — $HIMS surprised the market when $NVO dropped its lawsuit against the company and instead moved forward with a partnership.
No one saw this coming.
To be clear - NVO didn’t just d…↗
KaizenInvestor — My unpopular opinions
Mag 7: $GOOGL > $NVDA
Energy storage: $FLNC > $EOSE
Drone industry: $AMPX > $ONDS
Pharma: $HIMS > $NVO
Space Economy: $PL > $ASTS
Datacenter:…↗
Feb 23
Adam Feuerstein ✡️ — Novo Nordisk’s $NVO next-gen obesity drug stumbles in $LLY comparison study https://t.co/J4u8f9BHdB via @DrewQJoseph↗
Feb 23
The Future Investors — $NVO Novo Nordisk reported that CagriSema delivered 23% weight loss over 84 weeks but failed to match tirzepatide in a head-to-head trial.
The drug was well tolerated, with higher…↗
The Future Investors — What a week it was 😮
Next week looks just as intense 🔥
A full week of earnings:
$PLTR $AMD $LLY $NVO $UBER $ARM $QCOM $GOOGL $AMZN $IREN and many more 📊
Which one are you watc…↗
Jan 24
Mike Investing — We are vastly outperforming the markets yet again in just 24 days.
So far this year these picks were called out:
$ASTS +55%
$EOSE +45%
$IREN +42%
$PL +40%
$LMND +34%
$RKLB +30%…↗
Jan 23
Mike Investing — These things are next to happen:
$ASTS is going to $150, then slightly pulling back, & running to $220+.
$RKLB is squeezing to $140+ ahead of the SpaceX IPO.
$ZETA will pop 10/2…↗
Mike Investing — $NVO will see a V shape recovery back above the 200SMA at $83 very soon.
With a 3.7% dividend, 24% YoY revenue growth and a 25% YoY EPS $NVO is a safe haven.
At just a 12x P/E pr…↗
Dec 27
The Future Investors — 4 quality stocks having a tough year 🌠
Who’s your favourite rebound stock for 2026? ✨
Choose your fighter!🥊🚀
$ADBE $NVO $CRM $DUOL https://t.co/Y8MkvqCItn↗
Dec 26
Mike Investing — This year generational wealth was made via a wide variety of stock picks…
In 2025 I called out:
1. $ASTS at $36
2. $HOOD at $21
3. $PLTR at $62
4. $RKLB at $37
5. $TSLA at $210…↗
Mike Investing — These 7 stocks remain strong buys and will outperform the markets as we head into 2026…
1. $TSLA at $430
2. $SOFI at $29
3. $NVO at $49
4. $LULU at $180
5. $ORCL at $190
6. $OSCR…↗
Nov 27
Mike Investing — This year I’ve called the bottoms and caught…
1. $TSLA at $210
2. $LMND at $35
3. $NBIS at $62
4. $AMD at $75
5. $PLTR at $65
6. $HOOD at $30
While I do still really like these 6…↗
Nov 26
Mike Investing — These 7 stocks remain the Best Buy’s as we head into 2026, and are going to outperform the markets by a significant margin…
1. $META
2. $UNH
3. $NVO
4. $OSCR
5. $IREN
6. $SOFI
7.…↗
The Future Investors — $NVO $PFE $MTSR Novo Nordisk outbid Pfizer for U.S. biotech Metsera with a $9B offer, which Metsera called 'superior.' Pfizer slammed the move as "reckless." The deal strengthens N…↗
Oct 30
Adam Feuerstein ✡️ — M&A drama, with a dose of "America First" politics! So much fun...
Novo Nordisk $NVO makes offer for obesity-focused Metsera $MTSR, aiming to outbid Pfizer $PFE https://t.co/…↗
Oct 30
Adam Feuerstein ✡️ — $PFE calls $NVO bid for $MTSR "reckless and unprecedented..."
Also, Bourla playing his Trump card, literally...
"It is an attempt by a company with a dominant market position to…↗
Adam Feuerstein ✡️ — Scholar Rock $SRRK SMA drug rejected due to problems at $NVO -owned contract manufacturing site https://t.co/DFR1iOuvlc↗
Sep 12
Mike Investing — If you missed out on the $UNH rally then your next 3 opportunities are here and ready to breakout.
These next 3 setups are expected to run 200/300% over the next few months…
1. $…↗
Sep 10
Adam Feuerstein ✡️ — Novo Nordisk $NVO to cut 11% of workforce as it seeks to regain competitive edge https://t.co/xeqdsQy3wr via @DrewQJoseph↗
Sep 7
Mike Investing — As rotation in the market occurs in guidance to seasonality, healthcare stocks will now begin to powerfully outperform.
These 5 stocks will see extensive rally’s heading into Nove…
August 2025 · 8 mentions
Aug 21
Adam Feuerstein ✡️ — What a unique situation.... $NVO buys a manufacturing plant for Wegovy, but it's basically the worst facility in the U.S. and as a result, a bunch of other drug makers who use it…↗
Aug 21
Adam Feuerstein ✡️ — U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, FDA finds
Plant, once owned by $CTLT and now owned by Novo Nordisk $NVO, is widely u…↗
Aug 19
Adam Feuerstein ✡️ — "Pharm to table"
It's the clever buzzphrase bandied around by pharma insiders when promoting their plans to sell drugs directly to consumers.
Cut out the insurers and the PBMs…↗
Mike Investing — $HIMS is going to breakout above $100+ very soon…
Since the $HIMS & $NVO -35% deal termination dip $HIMS is now up over 57%+ and isn’t stopping anytime soon.
With 111% YoY re…↗
Jul 29
SpotGamma — $NVO is down 20% and IV's for downside strikes are down https://t.co/EIwcutVHRg↗
Jul 29
Adam Feuerstein ✡️ — Novo Nordisk $NVO names new CEO as it cuts growth outlook https://t.co/NdPiHrKwvR via @elaineywchen↗
Jul 29
SpotGamma — $NVO is getting "mercked" today - down 25% to ~50.
Interesting its <55 where options positions essentially cease to exist.
Given that, and my boredom with the 29bps expected…
— $HIMS wants to become the consumer-facing front door for healthcare but the market still needs proof the $NVO partnership can turn GLP-1 demand into profitable growth.
After the c…
Shay Boloor — $NVO says higher-dose Wegovy showed 27.7% average weight loss at 72 weeks in early responders.
A separate analysis found 84% of the weight loss came from fat mass with visceral fa…↗
May 9
Serenity — I feel like all the $FISV, $PYPL, $NVO value/dividend investors went extinct this cycle?
Was very popular, even last year…
But if you pivoted to semis like $INTC or $SNDK, you wo…↗
May 7
Shay Boloor — $AMZN Pharmacy is expanding access to $NVO oral Ozempic with same-day prescription delivery across nearly 3,000 U.S. cities.
Amazon also plans to add One Medical pickup kiosks and…↗
May 6
InvestmentGuru — $NVAX $NVO $OSCR all up 10%+
$NVAX Q1 EPS of $2.93 vs. -$0.43 estimate. Massive beat. Matrix-M adjuvant licensing model validating fast.
$NVO Q1 sales +32% to $15.2B. Wegovy hold…↗
May 6
The Future Investors — 𝗡𝗼𝘃𝗼 𝗡𝗼𝗿𝗱𝗶𝘀𝗸 𝗤𝟭 𝟮𝟬𝟮𝟲 𝗘𝗮𝗿𝗻𝗶𝗻𝗴𝘀 $NVO
EPS: $1.04 vs $1.10 est. ❌
Revenue: $10.87B vs $11.29B est. ❌
𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝟮𝟬𝟮𝟲
Revenue: -4% to -12% vs -7.4% es…↗
May 2
The Future Investors — Next week is absolutely packed with major earnings reports on deck 🚀
Monday: $PLTR, $DUOL
Tuesday: $SHOP, $AMD, $ANET, $TMDX
Wednesday: $NVO, $ADYEN, $UBER, $AXON
Thursday: $CRWV…↗
The Future Investors — $NVO Novo Nordisk partners with OpenAI to use AI across drug discovery and operations 🤖
AI will help find new treatments faster, improve efficiency, and speed up the path from re…↗
Apr 12
Black Panther Capital — This might be the biggest "tell" of 2026 so far. So please, sit with this for a second:
I was at Easter lunch yesterday with my father-in-law.
This guy has been a investor for 30…↗
Apr 7
KaizenInvestor — Looks like the $HIMS relationship with $NVO is fully restored.
The partnership first collapsed in June 25’, when $HIMS was at $61. https://t.co/nvIDjKKoHB↗
Apr 7
The Future Investors — $NVO Novo Nordisk’s Wegovy HD (7.2 mg) now available nationwide in the U.S. 💉🇺🇸↗
Apr 1
KaizenInvestor — 3 stock I think will bounce back in 2026.
1. $HIMS
HIMS is perfectly positioned to capture the new pharma wave. GLP-1 is still the fastest growing TAM outside AI. While the AI T…↗
Apr 1
Adam Feuerstein ✡️ — Eli Lilly’s $LLY obesity pill approved by FDA, setting up fierce competition with Novo Nordisk $NVO https://t.co/9mQ93N6Xe8 via @elaineywchen↗
— $NVO officially drops the lawsuit against $HIMS.
> no one expected this outcome so soon.
> lawsuits usually drag on for years.
> so this is a very positive news.
A lot o…
KaizenInvestor — It still strikes me how wrongly investors see the GLP-1 drugs. It is not an obesity drug, it is way more than that.
Last year I shared some research on $HIMS and why I think they…↗
Mar 9
mon — $NVO X $HIMS
They need each other to break out of this downward trend. https://t.co/FxqwIhRJ1y↗
Mar 7
Mike Investing — On Monday, $HIMS has the potential to make history…
$NVO has reportedly dropped the lawsuit, & partnered with $HIMS to sell NOVO branded GLP-1’s.
Institutions shorted 40% of $HIM…↗
Mar 7
The Future Investors — $HIMS $NVO Novo Nordisk and Hims & Hers Health are reportedly ending their legal feud and planning a partnership to sell obesity drugs like Wegovy on the Hims platform 💉💊
Hi…↗
Mar 7
KaizenInvestor — Huge news on $HIMS!
Looks like $NVO dropped the lawsuit and HIMS will sell Novo GLP-1 products again.
Huge win for both parties.
Very happy I added some shares in the last co…↗
Mar 1
Kevin Maro — @longinvest32 You feel strongly about $HIMS? I might buy 1k shares, but I feel like $NVO might be better just because americans are all fat pigs and Ozempic isn't going anywhere↗
— $NVO general counsel says in our interview:
$HIMS relies on "sham mass personalization of semaglutide."
HIMS' attempt to sell a compounded version of the Wegovy pill is "like th…
Adam Feuerstein ✡️ — Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel tells STAT in exclusive interview. $NVO $HIMS
https://t.co/YYgSUug19o via @elaineywch…↗
Feb 9
mon — $NVO sues $HIMS over cheaper copycat versions of Wegovy pill, injections - CNBC.
Stock down 20% pre-market.
$18.42 -> The same price as it was back in 2024. https://t.co/MuGya…↗
Feb 9
Adam Feuerstein ✡️ — BREAKING: Novo Nordisk $NVO sues Hims & Hers $HIMS for infringing on a key Wegovy patent https://t.co/44Ndx293d4 via @pharmalot↗
Adam Feuerstein ✡️ — HHS asks Justice Department to probe Hims & Hers $HIMS over its cheaper compounded version of $NVO Wegovy https://t.co/OGyGcy3lWM via @pharmalot↗
Feb 6
The Future Investors — $HIMS $NVO The FDA plans to restrict GLP-1 ingredients in non-approved compounded drugs, citing safety and legal concerns. The FDA also warned against misleading marketing, and Him…↗
Feb 6
The Future Investors — $NVO $LLY Trump launches online prescription drug platform TrumpRx claiming the lowest prescription drug prices globally.
Targets a wide range of medications, o.a. blockbuster GLP…↗
Feb 5
Adam Feuerstein ✡️ — Novo Nordisk $NVO accuses Hims & Hers $HIMS of ‘illegal mass compounding’ over a cheaper version of Wegovy pill https://t.co/l6xgvgPWNK via @pharmalot @damiangarde↗
Feb 5
The Future Investors — $HIMS $NVO Hims & Hers is launching a compounded pill version of Novo Nordisk’s Wegovy starting at $49 per month. The move undercuts the brand’s price and increases pricing pre…↗
Feb 3
Adam Feuerstein ✡️ — Novo Nordisk $NVO lowers sales, profits forecast as Wegovy faces growing competition https://t.co/MUm3l4KM8c via @elaineywchen↗
Feb 3
mon — This year has been a disaster for a number of companies.
Just today:
$PYPL -19%
$FUBO -21%
$NVO -14%
Another retail favorite backed by popular FinX influencers just hit a new low…↗
Feb 3
The Future Investors — 𝗡𝗼𝘃𝗼 𝗡𝗼𝗿𝗱𝗶𝘀𝗸 𝗤𝟰 𝟮𝟬𝟮𝟱 𝗘𝗮𝗿𝗻𝗶𝗻𝗴𝘀 $NVO
EPS: $1.02 vs $0.94 est. ✅
Revenue: $12.53B vs $12.17B est. ✅
𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝟮𝟬𝟮𝟲
Revenue: -5% to -13% vs -2.3% est…↗
Feb 3
Adam Feuerstein ✡️ — $NVO down sharply on early release of earnings, including weaker-than-expected sales guidance for 2026.↗
— $NVO has officially blown through its 200SMA confirming an incoming major squeeze…
With a 25% YoY EPS, 24% Revenue growth YoY, & only a 14x P/E, $NVO remains an obvious hold.…
The Future Investors — Glassdoor has shared its Best Places to Work for 2026 👥🏆
Below the most notable companies and their rankings 👇
3. $NVDA | Nvidia
7. $NOW | ServiceNow
11. $GOOGL | Alphabet
20.…↗
Jan 18
Mike Investing — I’m officially calling it…
$NVO will be the next healthcare stock to see an aggressive rebound rally towards ATH’s.
With 20% YoY revenue growth, 42%+ operating margins, $NVO has…↗
Jan 17
Mike Investing — Over the last few months my callouts have created many millionaires.
Many doubted me on…
$TSLA at $210 & ran to $499+
$IREN at $33 & ran to $59+
$ASTS at $35 & ran to $120+
$RKLB…↗
Jan 16
Mike Investing — You can create generational wealth simply by scrolling on X…
Over the past few weeks I’ve called out:
$ASTS at $35 & ran to $120+
$RKLB at $37 & ran to $98+
$IREN at $3…↗
Jan 16
The Future Investors — $NVO UK regulators approved a higher 7.2 mg weekly dose of Novo Nordisk’s Wegovy for obesity patients (BMI ≥30), expanding treatment options beyond the current 2.4 mg limit 💉🇬🇧…↗
Jan 15
Mike Investing — 2 weeks ago, I shared my top picks for 2026.
Since then…
$ONDS +40%
$ASTS +33%
$RKLB +26%
$NVO +15%
$NBIS +15%
$ZETA +10%
$BABA +10%
The main move for all these picks has yet t…↗
Jan 14
Adam Feuerstein ✡️ — $NVO CEO Mike Doustdar was our guest on this week's live taping of the Readout LOUD. And yes, he spoke fairly plainly about his ambition to acquire another developer of obesity dru…↗
Jan 13
Mike Investing — $NVO is the most undervalued healthcare stock, but it won’t stay this way for long …
There is a clear ongoing valuation gap between $LLY & $NVO despite them sharing the same GLP-1…↗
Jan 13
Mike Investing — These 6 sectors will greatly dominate the markets in 2026…
Space ~ $ASTS, $RKLB, $PL, $RDW
AI ~ $IREN, $NBIS, $ZETA
Healthcare ~ $NVO, $UNH, $OSCR
Drones ~ $ONDS
Robotics ~ $T…↗
Jan 11
Mike Investing — A portfolio involving these 10 picks will dominate & outperform the markets by a far margin in 2026…
1. $ONDS ~ Provides the secure & jam-resistant communication for autonomous dr…↗
Jan 10
Mike Investing — The healthcare sector is going to make a major comeback in 2026…
Here are 3 healthcare picks that you need in your portfolio to capture the incoming squeeze:
1. $NVO ~ A clear le…↗
Jan 9
Mike Investing — I’ve made generational wealth in 2025 for many, and I’ll do it yet again in 2026.
These are the 10 picks you need in your portfolio to succeed this year:
1. $ONDS ~ Autonomous de…↗
Jan 9
Mike Investing — There are 5 main sectors that’ll dominate the markets in 2026…
Space ~ $RKLB, $ASTS, $PL, $RDW
Drones ~ $ONDS
AI ~ $IREN, $NBIS, $ZETA
Robotics ~ $TSLA, $PATH, $RR
Healthcare…↗
Jan 9
Mike Investing — The 2026 stock picks have been on a historic run…
$ONDS +46%
$ASTS +39%
$NVO +14%
$RKLB +22%
$ZETA +21%
$NBIS +14%
$PATH +3%
$IREN +23%
$UNH +5%
This year is going to be life ch…↗
Jan 9
The Future Investors — $NVO $AMZN Amazon Pharmacy will sell Novo Nordisk’s FDA-approved Wegovy weight-loss pill, costing $25/month with insurance or starting at $149/month cash, with kiosk availability c…↗
Jan 9
Mike Investing — These 10 picks should all be in your portfolio for 2026…
1. $ONDS ~ building the next generation of autonomous, defense, security & drone systems.
2. $ZETA ~ enables AI powered cu…↗
Jan 9
Mike Investing — 2026 is going to be a year full of generational opportunities for growth stocks…
$ONDS will be $40+
$OSCR will be $32+
$NVO will be $85+
$ZETA will be $50+
$ASTS will be $220+…↗
Jan 7
Mike Investing — These sectors are going to dominate the markets in 2026, and should be your portfolio’s primary focus…
1. AI ~ $NBIS, $IREN, $PATH, $ZETA, $CIFR
2. Space ~ $ASTS, $RKLB, $PL
3.…↗
Jan 7
Mike Investing — I’ve said it before, and I’ll say it again…
You do not own enough $NVO.
$NVO is going to be the next healthcare stock to see an aggressive V shape rebound.
With a 25% YoY EPS, 2…↗
Jan 7
Mike Investing — There are 5 core sectors your portfolio needs to be focused on for 2026:
1. Space ~ $ASTS, $RKLB, $PL
These companies are building the next generation of space infrastructure.
2.…↗
Jan 5
The Future Investors — $NVO Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S. 💊🇺🇸
Available via major pharmacies & telehealth providers, starting at around $149/mont…↗
Jan 4
Mike Investing — These 5 sectors are going to lead the markets in 2026, and should be your primary focus…
1. Space ~ $ASTS, $RKLB, $PL
2. AI Infrastructure ~ $NBIS, $IREN, $CRWV
3. AI chips & Te…↗
Jan 3
Mike Investing — There are 4 main sectors your portfolio should be mainly focused upon for 2026…
1. AI & data centers ~ $NBIS, $IREN, $CIFR, $PATH, $ZETA
These picks power the AI boom through auto…↗
Jan 2
Mike Investing — There are 5 main sectors that will dominate the markets in 2026 that you need to be invested in…
Space ~ $ASTS, $RKLB
Drones ~ $ONDS
AI ~ $IREN, $NBIS, $ZETA
Robotics ~ $TSLA,…↗
Jan 1
Mike Investing — 6: Novo Nordisk ~ $NVO
Dominating the GLP-1 market, and with obesity and diabetes drugs driving demand; growth is visibly guaranteed this year.
With a 20%+ YoY revenue growth, 4…↗
Jan 1
Mike Investing — Below are the top 10 picks for 2026 that will most likely outperform the markets…
1. $ONDS
2. $ZETA
3. $NBIS
4. $IREN
5. $ASTS
6. $RKLB
7. $NVO
8. $TSLA
9. $AMZN
10. $PATH
Do not…↗
— I’m officially calling it…
$NVO is going to be the next healthcare stock to see a major V shape rally back into ATH’s territory in 2026.
Sitting at a 5 year low, and only at a 12…
Mike Investing — This year I bottom called and caught…
$TSLA at $210 and ran to $498+
$ASTS at $36 and ran to $102+
$RKLB at $37 and ran to $79+
$HOOD at $21 and ran to $153+
$PLTR at $62 and…↗
Dec 23
The Future Investors — $NVO The FDA approved the first GLP-1 weight-loss pill from Novo Nordisk, offering an oral alternative to Wegovy injections 💊💉
The pill launches in early 2026, priced from $149/…↗
Dec 23
Mike Investing — It’s obvious that $NVO is going to be the next healthcare stock to see an aggressive V shape recovery…
With a 25% YoY EPS, 24% Revenue growth YoY, and at just a 12x P/E shows how…↗
Dec 20
Mike Investing — These sectors are going to dominate 2026 and should be your top portfolio priorities…
Space: $ASTS, $RKLB
AI: $ZETA, $ORCL, $IREN, $NBIS, $PLTR, $AMD
Robotics: $TSLA, $RR, $ONDS…↗
Dec 12
Mike Investing — $NVO is clearly a no brainer to purchase at the current valuation it’s positioned at…
Sitting at a 5 year low & trading at just a 12x P/E shows just how undervalued $NVO reall…↗
Dec 4
Adam Feuerstein ✡️ — Last night at the CTAD meeting, $NVO presented the EVOKE studies of oral semaglutide in Alzheimer's disease.
It's hard to tell, but yes, there are two lines on each of those grap…↗
— $NVO is sitting at a 5 year low trading at just a 12x P/E…
It’s clear that $NVO will be the next healthcare stock to see a euphoric squeeze.
With 24% YoY revenue growth, 25% YoY…
Adam Feuerstein ✡️ — @A_May_MD Hasn't $NVO already reported amycretin ph2 results in obesity? In January?↗
Nov 25
The Future Investors — You have $100,000 to invest 💰
Two weight-loss titans are on the table — but you can only choose one for the next 5 years $LLY $NVO
Which do you pick, and why? 🤔 https://t.co/bf…↗
Nov 24
Adam Feuerstein ✡️ — Novo Nordisk’s $NVO semaglutide fails to slow Alzheimer’s progression https://t.co/UXa3LE12vW via @DrewQJoseph↗
Nov 24
The Future Investors — $NVO Novo Nordisk is down 12% after the Evoke trials showed semaglutide failed to slow Alzheimer’s progression, forcing the company to end the extension phase 📉 💉
Does this chan…↗
Nov 24
Adam Feuerstein ✡️ — $NVO oral semaglutide EVOKE studies in Alzheimer's fail.
https://t.co/RLpLhvJXTF↗
Nov 23
Mike Investing — I’m officially calling it…
$NVO is the next healthcare stock to see an aggressive rebound rally towards ATH’s.
With a 25% YoY EPS, 24% Revenue growth YoY, and meanwhile insiders…↗
Nov 21
Adam Feuerstein ✡️ — Next week: We will certainly see $CAPR and $NVO study readouts, right?↗
Nov 19
Adam Feuerstein ✡️ — $NVO Very few people believe oral sema studies in Alzheimer's will succeed. Yet, Novo posted job openings for Alzheimer's positions just days ago...
@elaineywchen previews the lo…↗
Nov 11
Adam Feuerstein ✡️ — @avidresearch We’ve asked $NVO. They’re not saying. Here’s the CTAD agenda. EVOKE trials presentation Weds Dec. 3 at 5:10 pm PT
https://t.co/Oi8yErnIE8↗
Nov 11
Adam Feuerstein ✡️ — @avidresearch Evoke trials are being presented at CTAD but unclear if $NVO is going to top-line results prior. They’re not saying.↗
Nov 6
Adam Feuerstein ✡️ — Also, both $LLY and $NVO are receiving FDA priority review vouchers as part of this government deal.↗
Nov 6
Adam Feuerstein ✡️ — Trump announces deal with Lilly, Novo to expand access to weight loss drugs, cut prices https://t.co/CVaCTfcAZI via @_daniel_payne @elaineywchen $LLY $NVO↗
Nov 6
Mike Investing — @mikealfred @ericjackson $NVO most definitely!!↗
Nov 5
Adam Feuerstein ✡️ — $NVO Novo CEO, in bidding war with Pfizer $PFE, says Metsera’s $MTSR drugs would complement pipeline https://t.co/d5PARiot1Z via @DrewQJoseph↗
Nov 5
The Future Investors — 𝗡𝗼𝘃𝗼 𝗡𝗼𝗿𝗱𝗶𝘀𝗸 𝗤𝟯 𝟮𝟬𝟮𝟱 𝗘𝗮𝗿𝗻𝗶𝗻𝗴𝘀 $NVO
EPS: $0.69 vs $0.66 est. ✅
Revenue: $11.52B vs $11.84B est. ❌
𝗢𝘂𝘁𝗹𝗼𝗼𝗸 𝟮𝟬𝟮𝟱
Revenue: 8.0%-11.0% vs 8.0% est.…↗
Nov 4
The Future Investors — $NVO $LLY Eli Lilly and Novo Nordisk are nearing a deal with the White House to price their obesity drugs at $149/month in exchange for Medicare coverage, potentially announced thi…↗
Nov 4
Adam Feuerstein ✡️ — Bidding war between Pfizer, Novo Nordisk $NVO for obesity startup Metsera $MTSR escalates
Next up: $PFE earnings call this morning
https://t.co/EViuZSlDhm via @elaineywchen↗
Nov 2
Mike Investing — These 5 stocks are the most undervalued in the entire market as of right now…
1. $NVO
2. $JD
3. $UNH
4. $ADBE
5. $PYPL
Expect these setups to see euphoric upside moves over the n…↗
Nov 1
The Future Investors — Next week we’re picking up right where we left off — with another busy wave of earnings ahead 📊
Monday: $PLTR, $HIMS
Tuesday: $UBER, $SHOP, $ANET, $AXON, $AMD
Wednesday: $NVO, $H…↗
— $NVO official bid for $MTSR. What will $PFE do?
https://t.co/yb3nQjGKAB
Adam Feuerstein ✡️ — FDA declares Novo Nordisk $NVO (Catalent) plant, key to drug manufacturing for some biotechs, out of compliance. Impacting $SRRK and $REGN today.
https://t.co/LLlei1xM7X via @el…↗
Oct 9
Adam Feuerstein ✡️ — Novo Nordisk $NVO to buy Akero Therapeutics $AKRO, picking up promising MASH drug https://t.co/NJhLwz1wHL↗
— These 5 stocks are at extreme oversold levels right now and all will see massive returns over the next few weeks…
$OSCR
$ZETA
$LMND
$NVO
$UNH
Don’t miss out on these once in a li…
Adam Feuerstein ✡️ — $NVO discontinued development of FGF21-targeted MASH drug zalfermin. $AKRO $ETNB↗
Aug 1
Adam Feuerstein ✡️ — $REGN regulatory update:
Expects Eylea HD pre-filled syringe and RVO approval delays (August PDUFAs) due to FDA general site inspection issues at Catalent's Indiana manufacturing…↗
Aug 1
Puru Saxena — There are NO "safe" stocks.
ALL stocks go through stages:
Stage 1 - base
Stage 2 - uptrend
Stage 3 - top
Stage 4 - downtrend
Even well-established companies' stocks decline 50…↗
Aug 1
Puru Saxena — This is NovoNordisk - a "safe" investment.
$NVO down 67% in a year!
Stage analysis would've booked your gain before this horrendous "Stage 4" decline. This is why we use "stage…↗